Infectious Diseases Collaboration and Licensing Deals 2019-2024


Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024

Publication date
April 2024
Number of pages
Product type
Research report
Report edition

Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious diseases deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of 1726 infectious disease deals from 2019 to 2024.

The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration and licensing deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of infectious diseases dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in infectious diseases dealmaking.

Chapter 3 covers the financial deal terms for deals signed in the infectious diseases field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.

Chapter 4 provides a review of the top 25 most active biopharma companies in infectious diseases dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive and detailed review of infectious diseases deals signed and announced since 2019 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of infectious diseases deals listed by theraeutic target.

The report also includes numerous table and figures that illustrate the trends and activities in infectious diseases deal making since 2019.

In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


Key benefits

Infectious Diseases Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2019
  • Browse infectious diseases collaboration and licensing deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time


Report scope

Infectious Diseases Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of infectious diseases trends and structure of deals entered into by leading biopharma companies worldwide.

Infectious Diseases Collaboration and Licensing Deals includes:

  • Trends in infectious diseases dealmaking in the biopharma industry
  • Overview of collaboration and licensing deal structure
  • Directory of infectious diseases deal records covering pharmaceutical and biotechnology
  • The leading infectious diseases deals by value
  • Most active infectious diseases licensing dealmakers

In Infectious Diseases Collaboration and Licensing Deals, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type

Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.

Infectious Diseases Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Infectious Diseases Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2019
  • Browse infectious diseases collaboration and licensing deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in infectious diseases dealmaking


2.1. Introduction

2.2. Infectious diseases partnering over the years     

2.3. Infectious diseases partnering by deal type

2.4. Infectious diseases partnering by industry sector

2.5. Infectious diseases partnering by stage of development

2.6. Infectious diseases partnering by technology type

2.7. Infectious diseases partnering by therapeutic indication


Chapter 3 – Financial deal terms for infectious diseases partnering


3.1. Introduction

3.2. Disclosed financials terms for infectious diseases partnering

3.3. Infectious diseases partnering headline values

3.4. Infectious diseases deal upfront payments

3.5. Infectious diseases deal milestone payments

3.6. Infectious diseases royalty rates


Chapter 4 – Leading infectious diseases deals and dealmakers


4.1. Introduction

4.2. Most active in infectious diseases partnering

4.3. List of most active dealmakers in infectious diseases    

4.4. Top infectious diseases deals by value


Chapter 5 – Infectious diseases contract document directory


5.1. Introduction

5.2. Infectious diseases partnering deals where contract document available


Chapter 6 – Infectious diseases dealmaking by therapeutic target


6.1. Introduction

6.2. Deals by infectious diseases therapeutic target


Deal directory


Deal directory – Infectious diseases deals by company A-Z 2019 to 2024

Deal directory – Infectious diseases deals by technology type 2019 to 2024


Deal type definitions


About Biopharma Research Ltd


Current Partnering

Current Agreements

Recent report titles from Current Partnering


Table of figures


Figure 1: Infectious diseases partnering since 2019

Figure 2: Infectious diseases partnering by deal type since 2019

Figure 3: Infectious diseases partnering by industry sector since 2019

Figure 4: Infectious diseases partnering by stage of development since 2019

Figure 5: Infectious diseases partnering by technology type since 2019

Figure 6: Infectious diseases partnering by indication since 2019

Figure 7: Infectious diseases deals with a headline value

Figure 8: Infectious diseases deals with upfront payment values

Figure 9: Infectious diseases deals with milestone payment

Figure 10: Infectious diseases deals with royalty rates

Figure 11: Active infectious diseases dealmaking activity since 2019

Figure 12: Top infectious diseases deals by value since 2019

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $9,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

3a-diagnostics, 3M, 3rd People’s Hospital of Shenzhen, 3SBio, 4Living Biotech, 7 Hills Pharma, 10X Genomics, 221b Foundation, A*STAR’ Institute of Molecular and Cell Biology, A-Alpha Bio, A2A Pharmaceuticals, Aanika Biosciences, Aardvark Therapeutics, Aarhus University, Abbott Laboratories, Abbvie, AbCellera Biologics, Abingdon Health, ABL Bio, Ablexis, Abnova, Aboundbio, Absolute Antibody, ABT Innovations, AbVacc, Abveris, Abzena, Academy of Military Medical Sciences (China), AC Bioscience, Accelerated Enrollment Solutions, Accelerate Diagnostics, AcedrA BioPharmaceuticals, Acelrx Pharmaceuticals, Acer Therapeutics, AchilleS Vaccines, Actinium Pharmaceuticals, Active Motif, Acumen Diagnostics, Acurx Pharmaceuticals, Ada Health, Adamis Pharmaceuticals, Adaptive Biotechnologies, Adaptive Phage Therapeutics, AdaptVac, Adeptrix, ADMA Biologics, Advaccine Biotechnology, Advanced Animal Diagnostics, Advanced BioNutrition, Advanced BioScience Laboratories, Advanced Regenerative Manufacturing Institute, Advanz Pharma, Advarra, AdventHealth, Aegea Biotechnologies, Aegis Life, Aerogen, Aerpio Pharmaceuticals, Aetion, Afero, Affinity Biosciences, Affinivax, AffyXell Therapeutics, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, Afrigen Biologics, AGC Biologics, Age Labs, Agena Bioscience, AgeX Therapeutics, Agile Biodetection, Agilent Technologies, AiCuris, AIkido Pharma, AIM ImmunoTech, Ainos, AINQA Health, AiPharma Global Holdings, Airway Therapeutics, AIT Therapeutics, Ajinomoto Bio-Pharma Services, Akers Biosciences, Akili Interactive Labs, Akribis Systems, Akshaya Bio, Akston Biosciences, Alamar Biosciences, Albert Einstein College of Medicine, ALBOT Technologies, Aldevron, AlgaEnergy, Algenex, Algernon Pharmaceuticals, Aligos Therapeutics, AlivaMab Discovery Services, Allecra Therapeutics, Almirall, Alnylam Pharmaceuticals, Alphamab Biopharmaceuticals, Altamira Pharma, Altasciences, Alterity Therapeutics, Altesa Biosciences, Altimmune, Altum Pharmaceuticals, Alveo Technologies, AM-Pharma, American Association for Laboratory Accreditation, American College of Chest Physicians, American Diabetes Association, American Type Culture Collection (ATCC), Amerimmune, Amerlux, Ametek, Amgen, Amicogen, Amicrobe, Amneal Pharmaceuticals, Amplyx Pharmaceuticals, AMS, Amyndas Pharmaceuticals, Amyris, AN2 Therapeutics, Analog Devices, AnGes MG, Anixa Biosciences, Antengene, Anteo Diagnostics, AnteoTech, Antios Therapeutics, Antisoma Therapeutics, Aphex BioCleanse Systems, Aphios, Appili Therapeutics, Applied Biology, Applied Botanics, Applied DNA Sciences, Applied Pharmaceutical Innovation, Aptagen, Aptahem, Aptitude Medical Systems, Aptorum Group, Aqemia, Aragen Bioscience, Arbor Biosciences, Arbutus, ARCA Biopharma, ArcDia, Arctoris, Arcturus Therapeutics, Ardigen, Ares Genetics, Argonne National Laboratory, Ariadne Genomics, Aridis Pharmaceuticals, Arisan Therapeutics, ARISE MD Integrative Medicine & Surgery, Arizona State University, Arkansas Children's Research Institute, Ark Biosciences, Arlington Scientific, Armata Pharmaceuticals, Armed Forces Medical Research Institute, Armis Biopharma, Arrevus, Arrowhead Pharmaceuticals, ArtemiLife, Artificial, Artizan Biosciences, Ascletis, Asep Medical, Assembly Biosciences, AstraZeneca, Atara Biotherapeutics, Atea Pharmaceuticals, Atomwise, Atossa Therapeutics, Atreca, Attana, Attillaps Holdings, ATUM, Auburn University, Audax Medical, Audere, Augmenta, AUM LifeTech, AuraVax Therapeutics, Aurobindo Pharma, Australian Medical Research Institute, Australian Research Council, Austrian Research Promotion Agency, Autonomous Medical Devices Incorporated, Avacta, Avails Medical, Avalon GloboCare, Avalon SteriTech, AvantGen, Avid Bioservices, AXIM Biotechnologies, Axis Lighting, Azitra, AzurRx BioPharma, Babson Diagnostics, Baebies, Barbara Ann Karmanos Cancer Institute, Barinthus Biotherapeutics, Baruch S Blumberg Institute, BASF, Basilea Pharmaceutica, Batavia Biosciences, Bateman Horne Center, Battelle, Bavarian Nordic, Bayer, Bayer CropScience, Baylor College of Medicine, BBI Solutions, BC Neuroimmunology, BC Platforms, Beckman Coulter, Becton Dickinson, BeiGene, Beijing Defengrei Biotechnology, Beijing Genomics Institute (BGI), Beijing Minhai Biotechnology, Belfor, Belkin, Berg, Berkeley Lights, Beroni Group, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, BetterLife Pharma, BGN Technologies, Bharat Biotech, BIA Separations, Big Eye Diagnostics, Bill and Melinda Gates Foundation, BillionToOne, Binex, Bintai Kinden, Binx Health, Bio-Rad Laboratories, Bio-Techne, BIOASTER, BioCanna Healthcare, BioCentriq, Biocept, BioComo, Biocon, BioCopy, BioCryst Pharmaceuticals, Biodesix, BioExcel Diagnostics, Biofabri, Biofactura, Bioforum, BioGX, Bioharmony Therapeutics, BioIQ, Biolexis, BioLink Life Sciences, BioMatrix Specialty Pharmacy, Biomedical Advanced Research and Development Authority, Biomeme, Biomerica, bioMerieux, Biomica, BiondVax, BioNet Holding, BioNTech, BionX Medical Technologies, BioPharma Plasma, Bio Products Laboratory, bioRASI, BioReference Laboratories, Biosenta, BioSig Technologies, BioSure, BioSymetrics, BioSyntagma, Biotechnology Industry Research Assistance Council, Biotest, BioVaxys, BioVersys, BitBiome, Blacksmith Medicines, Blackstone, Blanver, Blu Biotech, Bluejay Diagnostics, BlueJay Therapeutics, Blue Water Resolute Innovations, Blue Water Vaccines, BlueWillow Biologics, Boca Biolistics, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Boeing Company, Bohai Biomedical, Bold Therapeutics, Bonne Santé Group, Booz Allen, Boragen, Bosch, Boston Immune Technologies and Therapeutics, Boston University, Botanical Solution, Boulos and Cooper Pharmaceuticals, Bpifrance, BPL Medical Technologies, BravoVax, BreathTech, Brickell Biotech, Brigham and Women's Hospital, Brii Biosciences, Bristol-Myers Squibb, Brown University, Bruker, BTG, Bugworks, Burkhan Group, BurstIQ, Butantan Institute, C2Sense, Cadila Pharmaceuticals, California Institute for Biomedical Research, California Institute for Regenerative Medicine, Calithera Biosciences, Calliditas Therapeutics, Calvert Laboratories, Cambridge Consultants, Canadian Hub for Health Intelligence and Innovation in Infectious Diseases, Canadian Institutes of Health Research, Canary Health Technologies, Cancer Prevention and Research Institute of Texas, Cancer Research UK, CanSinoBIO, Cantex Pharmaceuticals, Cap Alter Pharma, Capricor Therapeutics, Caprisa, CARB-X, Cardea Bio, Cardiomatics, Care Access Research, CareDx, Caring Cross, CaroGen, Carterra, Cascade Chemistry, Case Western Reserve University, Catabasis Pharmaceuticals, Catalent, Catholic University Leuven, CCT Research, Ceapro, Celanese, Celdara Medical, Cellect Biotechnology, Cellix Bio, CellSafe, Celltrion, Cellvera, Celonic, Celularity, Cenetron, Centene, Center for Breakthrough Medicines, Center for Cancer and Blood Disorders, Centers for Disease Control and Prevention, Centivax, Centogene, Centre for Human Drug Research, Cepheid, Cerba HealthCare, Ceres Nanosciences, Certara, CerTest Biotec, Ceva Sante Animale, CGIAR International Livestock Research Institute, Chan Zuckerberg Initiative, Charak Foundation, Charite Universitatsmedizin Berlin, Chembio Diagnostics, Chengdu Kanghua Biological Products, Children's Hospital of Philadelphia, Chimerix, Chimeron Bio, China National Biotech Group (CNBG), China Resources Pharmaceutical Commercial Group International Trading, Chinese Academy of Sciences, ChromaDex, Chromocell, Chronolife, Chubu University, Chugai Pharmaceutical, CIC Health, Cidara Therapeutics, CimCure, Cincinnati Children’s Hospital Medical Center, Ciox Health, Cipher Pharmaceuticals, Cipla, Circassia, Circuit Clinical, CIRION BioPharma Research, Citius Pharmaceuticals, Citranvi Biosciences, City College of New York, City of Hope, Civica Rx, Clarametyx Biosciences, CLEAR, Clear Creek Bio, Cleared4, Cleveland Clinic, Climate Amplified Disease and Epidemics, ClinCapture, Clinical Trial and Consulting Services, Clinton Health Access Initiative, Clorox Company, Clover Biopharmaceuticals, CLX Health, CN Bio, CNS Pharmaceuticals, Co-Diagnostics, Coalition for Epidemic Preparedness Innovations, Cobra Biologics, Cocrystal Pharma, Codagenix, Codiak BioSciences, Coeptis Therapeutics, CohBar, Colombia Ministry of Health and Social Protection, Colorado State University, Columbia University, Commonwealth of Pennsylvania, ConserV Bioscience, Contakt World Technologies, ContraFect, Cooper Companies, COPD Foundation, CORAT Therapeutics, Cord Blood Registry, Cornell University, Corpometria Institute, Corteva Agriscience, Cosmo Pharmaceuticals, CosmosID, Covar Pharmaceuticals, COVAXX, CPT Medical, CQuentia, Creoptix, Crestone Pharma, Cristal Therapeutics, Croda, Cromos Pharma, Crozet BioPharma, CR Pharma, CSIR - Institute of Microbial Technology, CSIRO, CSL, CSL Behring, Cubic, Cue Health, Cullinan Oncology, Cumberland Pharmaceuticals, Cupron, Curapath, Curative, Curative Biotechnology, CURE Pharmaceutical, Curetis, CureVac, Curia, Curreio, Current Health, CVC, CVD Equipment, CyanVac, Cyclacel Pharmaceuticals, Cyclica, Cyclolab, Cystic Fibrosis Foundation, Cystron Biotech, Cytiva, CytoAgents, Cytocom, Cytodyn, CytoVale, Cytovance Biologics, CYTOVIA Therapeutics, Cyxone, Daewoong Pharmaceutical, Dalberg, Dalriada Drug Discovery, Dalton Pharma Services, Dante Labs, Dare Bioscience, Dartmouth-Hitchcock Medical Center, Dartmouth College, DaRui Biotech, DATANet Software Development, Datavant, Day Zero Diagnostics, DCN Diagnostics, Debiopharm, deCODE Genetics, Defender Pharmaceuticals, Defense Advanced Research Projects Agency, Defense Health Agency (US), Defense Threat Reduction Agency, Dell Medical School, DelSiTech, Denovium, Denso, Department of Defence, Department of Defense, Department of Health and Human Services, Department of Homeland Security, Dermapharm, Detect-Ion, Deverra Therapeutics, DevsHealth, Dewpoint Therapeutics, DiaSorin, Dicerna Pharmaceuticals, Diffusion Pharmaceuticals, DiNonA, Diomics, DiosCURE Therapeutics, DIOSynVax, DMTC, DoctorsOne Healthcare Systems, Domus Diagnostics, DongKoo Bio & Pharma, Donnelley Financial Solutions, Door Pharmaceuticals, Dr. Falk Pharma, Dr. Reddy's Laboratories, Drawbridge Health, Drexel University, Drugs for Neglected Diseases Initiative, Duke-NUS Graduate Medical School Singapore, Duke Clinical Research Institute (DCRI), Duke University, Duke University Medical Center, Durect, Dyadic International, Dymax, Dynavax Technologies, DynPort Vaccine Company, E25Bio, Ecolog International, Edesa Biotech, eGenesis, Eisai, Elanco, Elasmogen, ElectroCore, Elektrofi, Eleven Biotherapeutics, Eligo Bioscience, Eli Lilly, Elixirgen, Ellume, Emcure Pharmaceuticals, Emergent BioSolutions, Emergex Vaccines, Emery Pharma, Emory University, Empatica, Empowered Diagnostics, EmVenio Research, Enable Biosciences, ENA Respiratory, Endo International, Endpoint Health, Enesi Pharma, EnGeneIC, Enlivex, Ennaid Therapeutics, Ennocure MedTech, Enochian Biosciences, Entasis Therapeutics, Entos Pharmaceuticals, Environmental Protection Agency (USA), Enzo Biochem, Enzolytics, Enzymatica, Epidemiologic Solutions, EpiPointe, Epivax, EpiVax Therapeutics, Epygen Biotech, Equilab International, Erasmus University Medical Center, Essential Pharmaceuticals, eTheRNA immunotherapies, Ethos Laboratories, Ethris, Eurocine Vaccines, Eurofins Viracor, European Commission, European Innovation Council, European Investment Bank, European Prevention Center, European Union, Evah, Evaxion Biotech, Everest Medicines, Everest Pharma, Evergreen Therapeutics, EverlyWell, Eversana, Evofem Biosciences, Evogene, Evotec, EVQLV, Evrys Bio, Evvivax, Ewha Womans University, Exagen Diagnostics, ExcellGene, Excision BioTherapeutics, Excivion, ExeVir Bio, Exicure, eXmoor Pharma, Exothera, Experimental Drug Development Centre, ExpreS2ion Biotechnologies, ExScientia, ExThera Medical, Exyte, Eyam Vaccines and Immunotherapeutics, Eyegene, FairJourney Biologics, Farmacore Biotechnology, Fatro, Federal Ministry of Education and Research (BMBF), Feinstein Institute for Medical Research, Felix Biotechnology, Ferozsons Laboratories, FibroGenesis, Finnish Institute for Health and Welfare, Fio, First Wave Bio, FitBit, Flanders Innovation & Entrepreneurship, Flightpath Biosciences, Florica Therapeutics, Florida International University, FlowMetric, FluGen, Fluidigm, Fluxergy, Food and Drug Administration (FDA), ForDoz Pharma, Forge Therapeutics, Fosun Pharmaceutical, Foundation for Innovative New Diagnostics, Foundation for Neglected Disease Research, Fox Chase Chemical Diversity Center, Fraunhofer Institute for Molecular Ecology (IME), Frazier Healthcare Ventures, Frederick National Laboratory For Cancer Research, Fred Hutchinson Cancer Research Center, Frontier Scientific, Fujifilm, FUJIFILM SonoSite, Fujirebio Diagnostics, Fulgent Genetics, Fundacion Medina, FYR Diagnostics, G-Tech Bio, G42 Healthcare, Gaelan Medical, Gamaleya National Center, GAVI Alliance, GBS, GC Pharma, Gedeon Richter, GE Healthcare, GEn1E Lifesciences, Gene Bio Medical, GeneData, Genentech, Generation Biotech, Generex Biotechnology, Genetic Technologies, Genetron Health, GeNeuro, Genevant Sciences, Genexine, Genmab, Gennova Biopharmaceuticals, Genocea Biosciences, Genomadix, Genomma Lab Internacional, GenoScreen, GenScript Biotech, GensKey Medical Technology, George Mason University, George Washington University, GeoSeeq Foundation, GeoVax, German Cancer Research Center, German Federal Ministry of Education and Research, Getein Biotech, Gigagen, Gilead Sciences, Ginkgo BioWorks, Gladstone Institutes, Glaukos, Glenmark Pharmaceuticals, Global Access Diagnostics, Global Antibiotic Research and Development Partnership, Global Coalition for Adaptive Research, Global Development Incubator, Global Dx, Global Response Aid, Global Virus Network, Global WholeHealth Partners, GlycoPath, GNA Biosolutions, GNP Bioscience, Gnubiotics Sciences, Golden Mountain Partners, Google, Government of Canada, Government of India, Government of South Korea, GPCR Therapeutics, Gravitas Therapeutics, GreenBioAZ, Green Cross LabCell, Greenfield Global, Greenlight Biosciences, Greenwich LifeSciences, Griffith University, Grifols, Gritstone Bio, Group K Diagnostics, GSK, GSK Consumer Healthcare, GT Biopharma, GT Molecular, GTP Bioways, Hackensack Meridian Health, Hadassah Medical Center, Hai Kang Life, Hainan Sihuan Pharmaceutical, HAI Solutions, Halberd, Halodine, Halomine, HaloVax, Halozyme Therapeutics, Hamilton Company, HanaVax, Harbour Biomed, Harro Hofliger, Harvard Medical School, Harvard University, Hasten Biopharmaceutic, HDT Bio, Healion Bio, Healthe, Health Holland, HealthTrackRx, Health Vector, Heat Biologics, Hebrew University of Jerusalem, Helmholtz Centre for Infection Research, Helocyte, Hememics Biotechnologies, Hemex Health, Hennepin Life Sciences, Henry M. Jackson Foundation, Hetero India, Hetero Labs, HHS Technology Group, HiFiBio, Hikma Pharmaceuticals, HilleVax, Histogen, Hisun BioRay, HitGen, Hoffmann La Roche, Hologic, Hong Kong Polytechnic University, Hoowaki, Horizon Discovery, Horizon Europe, Hoth Therapeutics, Howard Hughes Medical Institute (HHMI), HP, Hsiri Therapeutics, Humanigen, Hvidovre Hospital, hVIVO, Hybridize Therapeutics, Hyloris Pharmaceuticals, Iaso Therapeutics, iBio, IBM, Icahn School of Medicine at Mount Sinai, ICB Pharma, Ichor Biologics, Ichor Medical Systems, Icon, Iconovo, Icosavax, IDBiologics, IDbyDNA, IdentifySensors Biologics, IDT Biologika, IFC, IGM Biosciences, Illumina, ImageMover, Imec, ImmBio, Immune Biosolutions, ImmuneCyte Life Sciences, Immune System Regulation, Immune Therapeutics, Immunexpress, ImmunityBio, Immunome, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoQure, ImmunoScape, ImmunoTek Bio Centers, Immunyx Pharma, Immuron, Imophoron, Imperial College London, ImQuest BioSciences, IncellDx, Indiana University, Indian Institute of Science Education and Research, IndyGeneUS AI, Infection Innovation Consortium, Infectious Disease Research Institute (IDRI), Infectolab Americas, Infex Therapeutics, Infinity BiologiX, Inflammatix, InflaRx, Infor, InfoRLife, InfYnity Biomarkers, Inhalon Biopharma, InnoCentive, InnoPharmax, Innosuisse, InnoTech Precision Medicine, Innovare, Innovate UK, Innovation Pharmaceuticals, Innovo, Inotrem, Inovio, Inovio Pharmaceuticals, Inserm, Inserm Transfert, Insilico Medicine, InSilicoTrials, Insmed Inc, Inspira Pharmaceuticals, Inspira Technologies, Inspirevax, Instem, Institute for Bioscience and Biotechnology Research, Institute for Systems Biology, Institute for Transformative Technologies, Institute of Human Virology, Institute of Materia Medica, Institute of Molecular Biology of Paraná (IBMP), Institute of Virology and Immunology, Institut Pasteur, INTACT Solutions, Integral Molecular, Integrated BioTherapeutics, Integrated Computer Solutions, Integumen, Intel, Intellego Technologies, Intent Solutions, Intermountain Healthcare, International AIDS Vaccine Initiative, International Center for Genetic Engineering and Biotechnology, International Isotopes, International Vaccine Institute (IVI), Intravacc, iNtRON Biotechnology, IntuitiveX, InveniAI, InvisiShield Technologies, InVixa, IONTAS, ipCapital Group, Ipsen, iQ Group, IQVIA, IRBM, IriSys, ISA Pharmaceuticals, IsoPlexis, Israeli National Authority for Technological Innovation, Israel Institute for Biological Research, Italfarmaco, ITOCO, Iwatani Group, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Agency for Medical Research and Development, Jayne Koskinas Ted Giovanis Foundation for Health and Policy, Jenner Institute, Jhpiego, Jiangsu Carephar Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, JN Nova Pharma, John Hopkins University School of Medicines, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, John Snow, Johnson & Johnson, Johnson & Johnson Innovation, Joincare Pharmaceutical, Jomo Kenyatta University of Agriculture and Technology, JSR, Jubilant Life Sciences, Jubilant Therapeutics, Jumpcode Genomics, Juniper Therapeutics, Junshi Biosciences, Just Biotherapeutics, Kaken Pharmaceutical, Kalos Therapeutics, Kamada, Kane Biotech, Kansas State University, Kantaro Biosciences, KARE Biosciences, Karius, Karolinska Institute, Karveer Meditech, Karyopharm Therapeutics, KBI BioPharma, KBio, Kedrion Biopharma, KELTIC Pharma, Kemin Industries, kENUP Foundation, Kenya Medical Research Institute, Kephera Diagnostics, Kermode Biotechnologies, Keyence, Kiadis Pharma, Kimer Med, Kindred Bio, Kineta, King Abdullah University for Science and Technology, Kings College London, Kinnear Pharmaceuticals, Kintor, Kleen Bee Labs, Kleo Pharmaceuticals, Komodo Health, Korea Advanced Institute of Science and Technology, Korrus, KPM Tech, Kukbo, KVK-Tech, Kyowa Hakko Kirin, L1 Systems, Laboratoire M2, Laboratorios Farmaceuticos Rovi, Laboratory Corporation of America, Lactiga, La Jolla Institute for Allergy & Immunology, La Jolla Pharmaceutical, LamdaGen, Latham BioPharm Group, Laurus Labs, Lavie Bio, Lawrence Livermore National Laboratory, Lawson Health Research Institute, Laxai Pharma, Leading BioSciences, Leiden University, Leidos, Leinco Technologies, Lenovo, Les Laboratoires Servier, Leukocare, Leyden Laboratories, LFB Biotechnologies, LFB Group, LianBio, LifeArc, Lifebit Biotech, LifeLabs Medical Laboratory Services, Ligand Pharmaceuticals, Light Chain Bioscience, LightDeck Therapeutics, Liminal BioSciences, LimmaTech Biologics, LinkBio, LinKinVax, Lion TCR, Lipigon Pharmaceuticals, LiteVax, Liverpool School of Tropical Medicine, Livzon Mabpharm, Locus Biosciences, LogicBio Therapeutics, LogicInk, Longhorn Vaccines and Diagnostics, Lonza, Loop Insights, Loreal, Louisiana State University, LSU Health Sciences Center, Lucence, Lucira Health, Lumen Biomedical, Luminarie, Luminex, LuminUltra, LumiraDx, Lumos Pharma, Lung Biotechnology, Lupin, Luxna Biotech, Lyndra Therapeutics, Lysando, Lytica Therapeutics, Macau University of Science and Technology, Macleods Pharmaceuticals, Macquarie University, Macromoltek, Macrostruct Holding & Consulting, Magle Chemoswed, Magnetrap, Mainz University Medical Centre, Maitri Health Technologies, Mammoth Biosciences, Manhattan BioSolutions, Mannin Research, MannKind Biopharmaceuticals, Manny Pacquiao Foundation, Mapp Biopharmaceutical, March of Dimes, Marinomed Biotechnologie, Markforged, Masimo, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mass General Brigham, Mateon Therapeutics, Mathematica, Matinas Biopharma, Matrix Biomed, Matrix Medical Network, MAVIDx, Max-Planck, Max Biopharma, Maxcyte, Maxim Biomedical, Max Planck Institute for Multidisciplinary Sciences, Mayo Clinic, MBio Diagnostics, McGill University, McMaster University, MD Biosciences, Medexus Pharmaceuticals, MedGene Bioscience, Medicago, Medical Research Futures Fund, Medical Technology Enterprise Consortium, Medical University of Vienna, Medicines Development for Global Health, Medicines Patent Pool Foundation, MediciNova, Medigen Vaccine Biologics, Medigus, MediMergent, MedinCell, Medison Pharma, Meditemi, Medivir, Medlab Clinical, Medolife Rx, Medytox, Meihua International Medical Technologies, Meitheal Pharmaceuticals, Melinta Therapeutics, Melior Pharmaceuticals, Mellow Hope Bio Chem, MeMed, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Menarini, Menarini Silicon Biosystems, Menon Biosensors, Mentholatum Company, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Meridian Bioscience, Mesa Biotech, Mesoblast, Metaclipse Therapeutics, MGI Tech, Michigan Medicine, Michigan State University, Micreos, Microbion, Microbiotix, Microbix Biosystems, MicroGEM, Micron Biomedical, Microsoft, Mid-Atlantic BioTherapeutics, miDiagnostics, Mie University, MigVax, MILA International, MiMedx, Mimetas, MinervaX, Ministry of Health (Denmark), Minnesota Health System, Miravo Healthcare, Mithra Pharmaceuticals, Mitsubishi UFJ Capital, Moberg Pharma, MOBILion Systems, Mobility Health, Model Medicines, Moderna, ModeX Therapeutics, Moksha8, Molbio Diagnostics, Molecular Biology Systems, Molecular Loop, Molecular Partners, Moleculin Biotech, MolGen, Mologic, Monash University, Monopar Therapeutics, Montefiore Health System, Montreal Heart Institute, Morehouse School of Medicine, Morgan Stanley, Mosaic ImmunoEngineering, Mount Sinai Health System, Mount Sinai Medical Center, MphRx, MRIGlobal, MSD, MSD Wellcome Trust Hilleman Laboratories, MSN Pharmaceuticals, Multi G, Multiplex Genomics, Mundipharma, MustGrow Biologics, Mycovia Pharmaceuticals, Mylab Discovery Solutions, Mylan Laboratories, Mylan Pharmaceuticals, Mymee, Mymetics, NanoDx, Nanomerics, Nanomix, Nanommune, NanoMosaic, Nanopharm, NanoPin Technologies,, NanoViricides, Nanowear, Nant Africa, NantKwest, Nanyang Technological University, Napo EU, Napo Pharmaceuticals, Nascent Biotech, National Academy of Sciences, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Cheng Kung University, National Healthcare Services (NHS), National Heart, Lung and Blood Institute, National Institute for Environmental Health Sciences, National Institute for Health Research (NIHR), National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Hygiene and Epidemiology, National Institute of Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Vaccines and Medical Biologicals, National Institute on Deafness and Other Communication Disorders, National Institutes of Biomedical Innovation, Health and Nutrition, National Institutes of Health, National Research Council Canada, National Research Council of Canada, National Science Foundation, Natural Sciences and  Engineering Research Council of Canada, Nature Technology, Naval Medical Research Center, Navamedic, Navigo Proteins, Navy Medical Research Centre, NEC, Nepean Blue Mountains Local Health District’s Nepean Hospital, Nestle Health Science, NeuMoDx Molecular, Neurimmune Therapeutics, Neurophotometrics, NeuroRx, New England Complex Systems Institute, New York Blood Center, New York City Health and Hospital, New York Presbyterian/Columbia, New York University, New Zealand's Foundation for Research, Science and Technology, Nexelis, Neximmune, Next Gen Diagnostics, Next Generation Manufacturing Canada, NexusBioAg, Nference, Nicoya, NiKang Therapeutics, Nimble Therapeutics, Ninety One, NMI Natural and Medical Sciences Institute, Noachis Terra, Nobelpharma, Nona Biosciences, Northeastern University, NorthStar Medical Radioisotopes, Northway Biotechpharma, Northwestern University, Norwegian Institute of Public Health, Norwegian Research Council, Noscendo, Nosopharm, NovAliX, Novan Therapeutics, Novartis, Novavax, NoveCite, Novellus Therapeutics, Novo, Novogene, Novo Nordisk, Novotech, Now Biopharma, NOWDiagnostics, Nrgene, NRx Pharmaceuticals, NTT Data, Nuance Pharma, NuGenerex Immuno-Oncology, Nykode Therapeutics, NYU Langone Medical Center, O2TODAY, Oak Ridge National Laboratory, Octant, Octapharma, Ocugen, ODx, Ohio State University, Olive Labs, OLM Diagnostics, Ology Bioservices, OmeCare, Omega Diagnostics Group, Omeros, Omniose, OmniPathology, OncoArendi Therapeutics, Oncogenuity, OncoImmune, Oncology Pharma, Oncology Venture, OncoMyx Therapeutics, OncoNano Medicine, Oncotelic, Ontera, Ontochem, Opal Therapeutics, Opencell Biomed, Open Philanthropy, Opentrons Labworks, OpGen, Opto-Systems, Oracle, Oragenics, Oramed Pharmaceuticals, OraSure Technologies, Oravax Medical, Organicell Regenerative Medicine, Organon, Orgenesis, Orion Biotechnology, Orna Therapeutics, Orpheus Medical, Ortho-Clinical Diagnostics, OSE Immunotherapeutics, Osivax, Oslo University Hospital, Oswaldo Cruz Foundation (Fiocruz), Otonomy, Otsuka, Owkin, Owlstone Medical, Oxford Biodynamics, Oxford Drug Design, Oxford Immunotec, Oxford Nanopore Technologies, Oxgene, Oxitec, OyaGen, Pacific GeneTech, PAI, Paion, Panacea Biotech, Pangea, Pan Probe Biotech, Pantherna Therapeutics, Paragon Genomics, Paratek Pharmaceuticals, Parexel, Parkway Clinical Laboratories, Partner Therapeutics, Path BioAnalytics, Pathnova Laboratories, Pathogen and Microbiome Institute, PathogenDx, Patient-Centered Outcomes Research Institute, PDS Biotechnology, Pebble Labs, Pennsylvania State University, PeptiDream, Peptilogics, PerkinElmer, Peter Doherty Institute for Infection and Immunity, Pfizer, Phagelux, Pharmaceutical Solutions, PharmaCyte Biotech, PharmaJet, Pharma Science, PharmEnable, Pharmsynthez, Phase Genomics, PHAXIAM Therapeutics, Phico Therapeutics, Phil, Philips, Philoseed, Phosphorus Genomics, PhysIQ, PIC, Pierre Fabre, Pinpoint Science, Planet Biotechnology, PlantForm, Plastomics, Plexision, Pluristem Therapeutics, Pluristyx, Pohang University Of Science And Technology, Polichem, Poly Group, Polyphor, PolyPid, Polyrizon, POSCO International, Poseida Therapeutics, PostEra, PPD, Praedicare, PRA Health Sciences, Prairie Hub for Pandemic Preparedness, Precisio Biotix Therapeutics, Precision Biomonitoring, Precision for Medicine, PrecisionLife, Precision NanoSystems, Precision Virologics, Predictmedix, Premas Biotech, Premier Inc, Prenetics, Prenosis, Prestige BioPharma, Prevencio, Prevenio, Primary Bio, Primetime Medical Software, Primordial Genetics, Princeton BioMeditech, ProBioGen, Procare Health, Procarta Biosystems, Profusa, Project to Accelerate New Treatments for Tuberculosis, Prokarium, Prokaryotics, Prometrika, ProMIS Neurosciences, ProteinLogic, Proteona, ProterixBio, Proteros biostructures, Providence Therapeutics, PROVIREX Genome Editing Therapies, Provista Diagnostics, Psyche Systems, PT Bio Farma, PT Etana Biotechnologies, P T Lloyd Pharma, Public Health England, Public Health Vaccines, Pulmatrix, Pulmonomy, Pulmotect, Pulthera, Purdue Research Foundation, Purdue University, Purna Pharmaceuticals, Purnovate, PWNHealth, Q-linea AB, Q2 Solutions, Q BioMed, Qiagen, Qilu Pharmaceutical, QMC HealthID, Qnovia, Qpex Biopharma, Qualigen, Quanterix, QuantumDx, Quantum Leap Health Care Collaborative, Quartesian Clinical Research, Qu Biologics, Quebec Government, Queen Mary University of London, Queensland University of Technology, Quercis Pharma, Quest Diagnostics, Quidel, Quotient, Quratis,, QureTech Bio, Qurient, R-Pharm, R4D Biotech, Rabian, Radient Technologies, Ragon Institute, Rapid Dose Therapeutics, Rapid Dx Laboratory, Rational Vaccines, ReAlta Life Sciences, Recce Pharmaceuticals, Recida Therapeutics, Recipharm, Redbiotec, RedHill Biopharma, Refana, Rega Institute for Medical Research, Regence, Regeneron Pharmaceuticals, Regnum, ReiThera, Relation Therapeutics, Relay Medical, Remington Pharmaceuticals, Renato Dulbecco Foundation, RenBio, Renegade Bio, Renibus Therapeutics, Rentschler Biotechnologie, Replicate Bioscience, Repligen, Repurpose.AI, Research Foundation to Cure AIDS, RespiraWorks, resTORbio, Resverlogix, Revelar Biotherapeutics, Revelation Biosciences, reViral, Revive Therapeutics, Reyon Pharmaceuticals, Rhinostics, Richard King Mellon Foundation, Ridgeback Biotherapeutics, Rigel Pharmaceuticals, Rigshospitalet, RIKEN Research Institute, Rising Pharmaceuticals, RNA Disease Diagnostics, Roche, Roche Consumer Health, Roche Diagnostics, Rockefeller University, RocketVax, Rokline Health Concepts, Rokote Laboratories, Romanian National Institute of Infectious Diseases, Romer Labs, Roncadelle Operations, Roswell Biotechnologies, Royal Philips Electronics, Royaltech Med, RQ Biotechnology, RTI International, Rubic One Health, Rush University Medical Center, Russian Direct Investment Fund, Ryerson University, SAB Biotherapeutics, Sabin Vaccine Institute, Saiba, SalesForce, Samsung Biologics, Samsung Electronics, Sanaria, Sandoz, Sanford Burnham Institute, Sanofi, Sanofi-Pasteur, Sano Genetics, SaNOtize Research and Development, Sanquin Blood Supply Foundation, Sapphiros, Saptalis Pharmaceuticals, Sarawak Infectious Disease Centre, Sarepta Therapeutics, Sartorius, Sartorius Stedim Biotech, SAS, Satio, SaudiVax, Scandinavian Biopharma, Scanwell Health, Scendea USA, SciClone Pharmaceuticals, Science 37, Science for Life Laboratory, Scilex Pharmaceuticals, Scipher Medicine, Scottish Enterprise, Scripps Research Institute, Scynexis, Seaspring, Seattle Childrens Research Institute, Secarna Pharmaceuticals, Seegene, SelectImmune Pharma, Selexis, Sema4, Sen-Jam Pharmaceutical, Senai Cimatec, Sensory Cloud, Sentinel Diagnostics, Seoul National University, Sepset Biosciences, Seqirus, Seraph Research Institute, Seres Therapeutics, SerImmune, Serum Institute of India, SevenScore Pharmaceuticals, Shanghai Haini Pharmaceutical, Shanghai Institute of Materia Medica, Shanghai Pharmaceutical, Shanghai Public Health Clinical Centre, Sharps Technology, Sheba Medical Center, Shenzhen Institutes of Advanced Technology, Shenzhen Smoore Technology, Sherlock Biosciences, Shijiazhuang Yuanmai Biotechnology, Shimadzu, Shionogi, Shionogi Pharma, Shyld, Siemens Healthineers, SIGA Technologies, SilcsBio, Simcere Pharmaceuticals, Simon Fraser University, Simulations Plus, Sinclair Research, Singlomics Biopharmaceuticals, Sino Biological, Sinotek-Advocates International Industry Development, Sinovac Biotech, SINTX Technologies, SiO2 Medical Products, Sirnaomics, Sirona Biochem, SK Bioscience, Skoll Foundation, Skymount Medical, SkyWater Technology, Smart Immune, SmartPharm Therapeutics, SmartShape Design, SMS Pharmaceuticals, SoftBank Robotics Group, Soligenix, SOM Biotech, Sona Nanotech, Sonata Scientific, Sonde Health, SOPHiA Genetics, Sorrento Therapeutics, SourceBio International, Source Molecular, Southern Research Institute, Southwest Research Institute, Spartan Medical, SpeeDx, Spero Therapeutics, Spicona, Spring Bank Pharmaceuticals, SpyBiotech, SQI Diagnostics, SRI International, St. Jude Children's Research Hospital, STADA Arzneimittel, Staidson (Beijing) BioPharmaceuticals, Stanford University, Statera Biopharma, Stavros Niarchos Foundation, St Elizabeth Healthcare, Stellenbosch University, Stemedica Cell Technologies, SteriLumen, St Georges University of London, Stone Diagnostics, Stony Brook University, Strategic Innovation Fund, Strategic Vaccines, Strides Arcolab, Strides Pharma Science, St Thomas University, Suanfarma, Sumaya Biotech, Summit Biosciences, Summit Therapeutics, Sun Pharmaceutical, Sun Pharma Global, Sunshine Biopharma, Sunstone Capital, Sun Yat-sen University, Surfacide, SutroVax, Suzhou NeuPharma, Suzhou Porton Advanced Solutions, Swedish Research Council, Swift Biosciences, SymBio Pharmaceuticals, Symphogen, Symvivo, Synairgen, Synbal, Synertex, Synexa Life Sciences, Syngene International, Syntegra, Syntekabio, Syracuse University, T2 Biosystems, Tabuk Pharmaceutical, Tabula Rasa HealthCare, Taiba, TaiGen Biotechnology, TaiMed, Taisho Pharmaceutical, Taiwan Liposome Company, Takara Bio USA, Takeda Pharmaceutical, Takis Biotech, Talem Therapeutics, Targeted Pharmaceutical, Tauriga Sciences, TAXIS Pharmaceuticals, TB Alliance, TC BioPharm, Tecan, Tech Innovation Global, Techmer PM, Technogenetics, TechnoVax, Tektronix Component Solutions, Telcon RF Pharmaceuticals, Tempus, TenNor Therapeutics, Tetherex Pharmaceuticals, Tetra Bio-Pharma, Tetraphase Pharmaceuticals, Teva Pharmaceutical Industries, Tevogen Bio, Texas A&M University, Texas Biomedical Research Institute, Texas Lung Injury Institute, TFF Pharmaceuticals, The Binding Site, The International AIDS Vaccine Initiative, The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center, Themis Bioscience, The Native Antigen Company, Therapeutic Solutions International, Therapyx, Therma Bright, Thermo Fisher Scientific, Thomas Jefferson University, Thylacine Biotherapeutics, Tianjin CanSino Biotechnology, Tianjin University, Tiba Biotech, TLC BioSciences, Todos Medical, Tokai University, TONIX Pharmaceuticals, Toray, Torrent Pharmaceuticals, Total Testing Solutions, Totient, Touchlight, Toyohashi University of Technology, Toyota Tsusho, Trans-Hit Bio, Translate Bio, Translational Genomics Research Institute, Transtoxbio, Trellis Bioscience, Trevena, TrialSpark, Tried & Tested, TriLink BioTechnologies, Trinomab Biotech, True Diagnostics, TSB Therapeutics, TScan Therapeutics, Tsinghua University, TTP Group, Tufts Medical Center, Tufts University, Tulane University, Turn Therapeutics, Twist Bioscience, Tyber Medical, U-Diagnostics, U.K. Department for International Development, Ubiquitome, Ubirch, UgenTec, UK Government, Ultromics, UNION Therapeutics, UniQuest, Unison Medicines, Unisys, UNITAID, United BioPharma, UnitedHealth, United Therapeutics, Univercells, University College London, University Gottingen, University Health Network, University Hospital Bonn, University Hospital Heidelberg, University Hospital Jena, University of Aberdeen, University of Adelaide, University of Alabama, University of Alabama at Birmingham, University of Alberta, University of Amsterdam, University of Antwerp, University of Arizona, University of Arkansas, University of Birmingham, University of Bonn, University of British Columbia, University of Buffalo, University of Calgary, University of California, Davis, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California San Francisco, University of Campinas, University of Chicago, University of Connecticut, University of Dundee, University of Edinburgh, University of Florida, University of Georgia, University of Hawaii, University of Hong Kong, University of Houston, University of Illinois, University of Illinois at Chicago, University of Kentucky, University of Lausanne, University of Leuven, University of Liverpool, University of Louisville, University of Maryland, University of Maryland, Baltimore County, University of Maryland Baltimore, University of Maryland School of Medicine, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Michigan, University of Minnesota, University of Montreal, University of Nebraska, University of New South Wales, University of Nottingham, University of Oklahoma, University of Ottawa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Pittsburgh Medical Center, University of Queensland, University of Saskatchewan, University of Southampton, University of Strathclyde, University of Sydney, University of Technology Sydney, University of Tennessee, University of Texas, University of Texas Health Science Center at Houston, University of Texas Health Science Center at Tyler, University of Texas Medical Branch, University of the Witwatersrand, University of Toronto, University of Tubingen, University of Vermont, University of Virginia, University of Washington, University of Waterloo, University of Wisconsin-Madison, University of Zagreb, University of Zaragoza, University of Zurich, US Air Force, US Army, US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Biologic, US Department of Agriculture, US Government, US Navy, Utrecht University, UV Partners, Vaccitech, Vaccizone, Valent Biosciences, Valneva, Valo Therapeutics, Vancouver Infectious Diseases Centre, Vanda Pharmaceuticals, Vanderbilt University, Variation Biotechnologies, Vault Health, VaxAlta, Vaxart, Vaxcyte, Vaxess Technologies, Vaxil BioTherapeutics, Vaxine, VaxNewMo, VaxThera, Vaxxas, Vayyar Imaging, VBI Vaccines, Vectans Pharma, Vector Institute, Vectura, Vedanta Biosciences, Veeva Systems, Vela Diagnostics, Velox Biosystems, VenatoRx, Veracyte, Vera Therapeutics, Veravas, Verily, Veristat, Vernalis, Verndari, Versatope Therapeutics, Versiti Blood Research Institute, Vetophage, ViaClean Technologies, Viatris, VIB, Vibrent Health, Vicore Pharma, Victoria University, Vidscrip, ViiV Healthcare, Vinbiocare Biotechnology, Vinnova, Vipergen, ViralClear Pharmaceuticals, Viravaxx, Virbac, Vir Biotechnology, Virex Health, Virginia Catalyst, Virginia Commonwealth University, Viriom, Virion Therapeutics, Virios Therapeutics, Viroclinics Biosciences, Virpax Pharmaceuticals, Virusight Diagnostics, Visby Medical, Vita Bee Health, VitalHub, VitriVax, Vituity, Vivacelle Bio, Vivera Pharmaceuticals, Voltron Therapeutics, Vortran Medical, Vyera Pharmaceuticals, Vyv, Wageningen University, Walter and Eliza Hall Institute, Washington University in St Louis, Watchmaker Genomics, Weill Cornell Medical College, Weizmann Institute, Wellcome Trust, Westlake Pharma, Westport Bio, Willow Biosciences, Wipro, Wistar Institute, WorldIPI, WPD Pharmaceuticals, WuXi Biologics, Wuxi STA, Wyss Institute, X-chem, Xanadu Bio, Xavier University of Louisiana, Xediton Pharmaceuticals, Xencor, Xerox, Xinhua Healthcare Industry, Xortx Therapeutics, XPhyto Therapeutics, XPRIZE Pandemic Alliance, Y2X Life Sciences, Yale Cancer Center, Yale School of Medicine, Yale University, Yunnan Walvax Biotech, ZabBio, ZebiAI Therapeutics, Zelluna Immunotherapy, ZeptoMetrix, Zeteo Tech, Zhejiang Jiuzhou Pharmaceutical, Zhifei Lvzhu Biopharmaceutical, Zoetis, Zoic Labs, Zuellig Pharma China, Zumutor Biologics, Zydus Cadila, Zymeworks, Zymo Research, ZYUS Life Sciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.